MARSHALL WACE, LLP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$426,683
+41.9%
234,441
+295.3%
0.00%0.0%
Q4 2022$300,691
+17.5%
59,308
+15.0%
0.00%0.0%
Q3 2022$256,000
-70.3%
51,590
-66.3%
0.00%
-50.0%
Q1 2022$861,000
-41.9%
153,282
-37.1%
0.00%
-33.3%
Q4 2021$1,481,000243,5190.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$933,2710.26%
ALLEN HOLDING INC /NY 687,571$1,911,4470.26%
Clearwater Capital Advisors, LLC 394,599$1,096,9860.13%
SHEETS SMITH WEALTH MANAGEMENT 269,129$748,1790.11%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$268,0840.10%
WEALTH EFFECTS LLC 71,000$197,3800.09%
Virtus ETF Advisers LLC 37,888$105,3290.06%
DARK FOREST CAPITAL MANAGEMENT LP 203,659$566,1720.05%
Bell & Brown Wealth Advisors, LLC 20,100$55,8780.03%
FISHMAN JAY A LTD/MI 162,000$450,3600.03%
View complete list of IMMUNITYBIO INC shareholders